Faeth Therapeutics Grants New Employees Options for 17,000 Shares
Faeth Therapeutics granted three new employees options to purchase an aggregate of 17,000 shares under Nasdaq Listing Rule 5635(c)(4).
Faeth Therapeutics granted three new employees options to purchase an aggregate of 17,000 shares under Nasdaq Listing Rule 5635(c)(4).